News Coverage - Parker Institute for Cancer Immunotherapy

Research
Network
News
About
Donate

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Donate

Medical Xpress

03.10.20

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

Read

GEN

03.10.20

June Lab Delivers CRISPR Safety Message in Cancer Clinical Trial

Read

Healthline

03.10.20

CRISPR-Edited Immune Cells Survive for Months and Still Kill Cancer

Read

STAT News

01.14.20

Innovation in biotech R&D: New resources offer new hope

Read

Endpoints

12.24.19

The top 10 most popular Endpoints News pieces of 2019 — going viral is a whole new game in biopharma now

Read

Genetic Engineering & Biotechnology News

12.02.19

Top 10 Immuno-Oncology Startups of 2019

Read

Medscape

11.25.19

Harnessing the Power of Microbes to Fight Cancer

Read

HemOnc Today

11.25.19

UCLA Opens Clinical Trial of Bispecific CAR T-cell Therapy for Advanced Lymphoma, Leukemia

Read

Inside Philanthropy

11.25.19

Status Update: How Facebook’s Billionaires Are Changing the World of Philanthropy

Read

FierceBiotech

11.25.19

Could this immuno-oncology combo treat metastatic prostate cancer?

Read

The Conversation

11.25.19

How gene-edited white blood cells are helping fight cancer

Read

Myeloma Research News

11.13.19

CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests

Read